Sorry for the inconvenience.

Chinese users are only allowed to visit websites which complies with the PIPL (Personal Information Protection Law of the People's Republic of China) effective November 1st.

▲ Scan or click the QR code to visit 三星医疗

The personal information of existing chinese users will be kept until October 29th and will be safely deleted thereafter.

Upgrade browser for full Samsung Healthcare experience

It looks like you may be using a web browser that we don’t support.
Make sure you’re using one of these recommended browsers,
or upgrade your browser by clicking the icons, to get the full Samsung Healthcare experience.

To check which browser you use
본문 바로가기


Experience the advances and contributions we have made


IOTA-ADNEX, Assessment of different neoplasias in the adnexa (ADNEX) model in ultrasound system

  • #Ultrasound System>Womens Health
  • writerSamsung Medison
  • date2019.01.03
Ovarian cancer causes more deaths than any other cancer of the female reproductive system and is the fifth leading cause of cancer-related deaths among women in the United States. Currently, the five-year relative survival rate is 47% for all types of ovarian cancer.1 If ovarian cancer is found and treated before the cancer has spread outside the ovary, the five-year relative survival rate is 92%. Sadly, only 15% of all ovarian cancers are diagnosed at this early stage, because the symptoms are vague or similar to other common illnesses. A combination of early diagnosis and centralized management is thought to be a key factor to optimize survival. However, because the true nature of the disease is unknown before surgery, a large proportion of women with ovarian cancer are still treated by general surgeons, although such centralized care is recommended.